Novavax (NVAX) Short Interest Ratio & Short Volume $17.11 +0.44 (+2.64%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Novavax Short Interest DataCurrent Short Interest31,400,000 sharesPrevious Short Interest29,530,000 sharesChange Vs. Previous Month+6.33%Dollar Volume Sold Short$474.77 millionShort Interest Ratio1.9 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares140,400,000 sharesPercentage of Shares Shorted22.36%Today's Trading Volume7,135,053 sharesAverage Trading Volume7,195,673 sharesToday's Volume Vs. Average99% Short Selling Novavax ? Sign up to receive the latest short interest report for Novavax and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNVAX Short Interest Over TimeNVAX Days to Cover Over TimeNVAX Percentage of Float Shorted Over Time Ad DTIWe’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! Novavax Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202431,400,000 shares $474.77 million +6.3%N/A1.9 $15.12 6/30/202429,530,000 shares $373.85 million -25.6%N/A1.9 $12.66 6/15/202439,710,000 shares $571.82 million +3.9%N/A2.6 $14.40 5/31/202438,210,000 shares $574.30 million -15.6%N/A2.7 $15.03 5/15/202445,290,000 shares $584.24 million +0.8%N/A3.5 $12.90 4/30/202444,930,000 shares $194.55 million +2.7%N/A6.6 $4.33 Get the Latest News and Ratings for NVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. 4/15/202443,770,000 shares $180.33 million -0.3%N/A6.1 $4.12 3/31/202443,910,000 shares $209.89 million -8.8%N/A5.5 $4.78 3/15/202448,130,000 shares $254.61 million -8.7%N/A5.6 $5.29 2/29/202452,740,000 shares $260.54 million -3.8%N/A5.5 $4.94 2/15/202454,830,000 shares $235.77 million +5.3%N/A6.4 $4.30 1/31/202452,090,000 shares $208.36 million +2.3%N/A6.9 $4.00 1/15/202450,910,000 shares $233.17 million +3.5%N/A7 $4.58 12/31/202349,200,000 shares $236.16 million +8.0%N/A6.5 $4.80 12/15/202345,540,000 shares $245.92 million +5.6%N/A6 $5.40 11/30/202343,110,000 shares $237.11 million +4.8%N/A5.6 $5.50 11/15/202341,150,000 shares $255.13 million -8.4%N/A4.7 $6.20 10/31/202344,910,000 shares $299.10 million +4.5%N/A4.7 $6.66 10/15/202342,990,000 shares $303.08 million -3.3%N/A4.3 $7.05 9/30/202344,440,000 shares $321.75 million -0.1%N/A4.7 $7.24 9/15/202344,500,000 shares $343.10 million +11.0%N/A5 $7.71 8/31/202340,090,000 shares $320.72 million +0.7%N/A4.7 $8.00 8/15/202339,800,000 shares $288.15 million +7.7%N/A5.6 $7.24 7/31/202336,950,000 shares $342.90 million +0.7%N/A5.5 $9.28 7/15/202336,690,000 shares $318.47 million +0.7%N/A6.1 $8.68 6/30/202336,450,000 shares $270.82 million +18.2%N/A5.8 $7.43 6/15/202330,840,000 shares $248.57 million +2.7%N/A5.3 $8.06 5/31/202330,030,000 shares $241.74 million -6.0%N/A5.2 $8.05 5/15/202331,930,000 shares $258.95 million -5.0%N/A5 $8.11 4/30/202333,600,000 shares $257.71 million -1.6%N/A5.4 $7.67 4/15/202334,150,000 shares $312.81 million -9.6%N/A5.5 $9.16 3/31/202337,770,000 shares $261.75 million +13.6%N/A5.9 $6.93 3/15/202333,240,000 shares $196.12 million -2.6%N/A5 $5.90 2/28/202334,110,000 shares $315.86 million +6.4%N/A4.6 $9.26 2/15/202332,050,000 shares $326.59 million +3.9%N/A4.7 $10.19 1/31/202330,840,000 shares $336.46 million -0.2%N/A4.5 $10.91 1/15/202330,910,000 shares $379.88 million +1.6%N/A4.7 $12.29 12/30/202230,410,000 shares $312.61 million +24.3%N/A4.5 $10.28 12/15/202224,470,000 shares $277.00 million +3.8%N/A3.9 $11.32 11/30/202223,570,000 shares $388.67 million +4.4%N/A4.7 $16.49Prepare for a Recession Unlike Any Other (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE 11/15/202222,580,000 shares $524.31 million +0.6%N/A4.7 $23.22 10/31/202222,450,000 shares $499.96 million +5.1%N/A4.5 $22.27 10/15/202221,360,000 shares $420.15 million +9.5%N/A4 $19.67 9/30/202219,500,000 shares $354.90 million +14.6%N/A3.2 $18.20 9/15/202217,020,000 shares $554.00 million +9.0%N/A2.8 $32.55 8/31/202215,620,000 shares $516.08 million +0.8%N/A2.4 $33.04 8/15/202215,490,000 shares $655.23 million -5.1%N/A2.1 $42.30 7/31/202216,330,000 shares $890.15 million +8.9%N/A2.2 $54.51 7/15/202214,990,000 shares $815.91 million +1.4%N/A2.1 $54.43 6/30/202214,780,000 shares $760.14 million -6.0%N/A2.3 $51.43 6/15/202215,730,000 shares $648.55 million +30.0%N/A2.7 $41.23 5/31/202212,100,000 shares $669.49 million -15.3%N/A2.2 $55.33 5/15/202214,290,000 shares $741.51 million +17.4%N/A3.1 $51.89 4/30/202212,170,000 shares $548.50 million +0.4%N/A2.7 $45.07 4/15/202212,120,000 shares $709.63 million +11.3%N/A2.6 $58.55 3/31/202210,890,000 shares $802.05 million +7.6%N/A2.2 $73.65 3/15/202210,120,000 shares $746.86 million +5.0%N/A1.8 $73.80 2/28/20229,640,000 shares $803.69 million +1.8%N/A1.6 $83.37 2/15/20229,470,000 shares $825.12 million +2.7%N/A1.5 $87.13 1/31/20229,220,000 shares $863.91 million -4.0%N/A1.5 $93.70 1/15/20229,600,000 shares $1.06 billion +7.5%N/A1.6 $110.82 12/31/20218,930,000 shares $1.28 billion +6.7%N/A1.5 $143.07 12/15/20218,370,000 shares $1.50 billion +8.1%N/A1.5 $179.49 11/30/20217,740,000 shares $1.61 billion -10.1%N/A1.5 $208.63 11/15/20218,610,000 shares $1.48 billion +4.5%N/A1.8 $172.45 10/29/20218,240,000 shares $1.23 billion +33.8%11.2%1.5 $148.83 10/15/20216,160,000 shares $997.61 million +1.5%8.4%1.1 $161.95 9/30/20216,070,000 shares $1.26 billion -9.1%8.2%1.2 $207.31 9/15/20216,680,000 shares $1.55 billion +9.9%9.1%1.4 $232.30 8/31/20216,080,000 shares $1.45 billion -15.3%8.3%1.2 $238.54 8/13/20217,180,000 shares $1.85 billion +21.9%9.8%1.4 $257.27 7/30/20215,890,000 shares $1.06 billion -2.6%8.0%1.3 $179.33 7/15/20216,050,000 shares $1.08 billion -0.5%8.2%1.4 $179.14 6/30/20216,080,000 shares $1.29 billion +5.0%8.3%1.5 $212.31 6/15/20215,790,000 shares $1.08 billion -0.3%7.9%1.5 $187.07 5/28/20215,810,000 shares $857.67 million +10.9%7.9%1.7 $147.62 5/14/20215,240,000 shares $634.04 million +17.8%N/A1.5 $121.00 4/30/20214,450,000 shares $1.06 billion -5.3%N/A1.2 $237.53 4/15/20214,700,000 shares $946.30 million +9.6%N/A1.1 $201.34 3/31/20214,290,000 shares $743.54 million -13.3%N/A1 $173.32 3/15/20214,950,000 shares $1.00 billion -7.1%N/A1.1 $202.77 2/26/20215,330,000 shares $1.18 billion -13.1%N/A1.2 $221.50 2/12/20216,130,000 shares $1.83 billion -1.1%N/A1.2 $298.26 1/29/20216,200,000 shares $830.86 million -11.1%N/A1.2 $134.01 1/15/20216,970,000 shares $905.96 million -4.9%N/A1.7 $129.98 12/31/20207,330,000 shares $871.98 million +1.4%N/A1.8 $118.96 12/15/20207,230,000 shares $937.73 million -19.4%N/A1.8 $129.70 11/30/20208,970,000 shares $1.13 billion +3.0%N/A2.1 $125.69 11/15/20208,710,000 shares $841.39 million +8.9%N/A2 $96.60 10/30/20208,000,000 shares $701.04 million +7.7%N/A1.6 $87.63Prepare for a Recession Unlike Any Other (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE 10/15/20207,430,000 shares $830.38 million -5.0%N/A1.3 $111.76 9/30/20207,820,000 shares $847.30 million -4.8%N/A1.2 $108.35 9/15/20208,210,000 shares $905.89 million -3.2%N/A1.1 $110.34 8/31/20208,480,000 shares $935.68 million +6.0%N/A1.1 $110.34 8/14/20208,000,000 shares $1.17 billion -0.5%N/A1 $146.51 7/31/20208,040,000 shares $1.15 billion -1.1%N/A0.8 $143.10 7/15/20208,130,000 shares $903.65 million -14.4%N/A0.9 $111.15 6/30/20209,500,000 shares $791.83 million +17.1%N/A1 $83.35 6/15/20208,110,000 shares $414.18 million +9.6%N/A0.9 $51.07 5/29/20207,400,000 shares $340.70 million +0.5%N/A0.8 $46.04 5/15/20207,360,000 shares $321.12 million +28.9%N/A0.7 $43.63 4/30/20205,710,000 shares $103.52 million +54.3%N/A0.7 $18.13 4/15/20203,700,000 shares $64.86 million +4.5%N/A0.4 $17.53 3/31/20203,540,000 shares $70.20 million -34.3%N/A0.4 $19.83 3/13/20205,384,600 shares $91.81 million +4.8%N/A0.6 $17.05 2/28/20205,140,000 shares $55.31 million -14.6%N/A0.8 $10.76 2/14/20206,020,000 shares $64.11 million +2.9%N/A1.4 $10.65 1/31/20205,850,000 shares $53.94 million +15.8%N/A1.6 $9.22 1/15/20205,050,000 shares $36.41 million -6.8%N/A1.6 $7.21 12/31/20195,420,000 shares $42.28 million +9.3%N/A5 $7.80 9/15/20194,890,000 shares $29.10 million +1.7%20.6%5.3 $5.95 NVAX Short Interest - Frequently Asked Questions What is Novavax's current short interest? Short interest is the volume of Novavax shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 31,400,000 shares of NVAX short. Learn More on Novavax's current short interest. What is a good short interest ratio for Novavax? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVAX shares currently have a short interest ratio of 2.0. Learn More on Novavax's short interest ratio. Which institutional investors are shorting Novavax? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novavax: Walleye Trading LLC, Ikarian Capital LLC, SG Americas Securities LLC, Capstone Investment Advisors LLC, and BNP Paribas Financial Markets. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Novavax's short interest increasing or decreasing? Novavax saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 31,400,000 shares, an increase of 6.3% from the previous total of 29,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Novavax's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Novavax: Iovance Biotherapeutics, Inc. (26.35%), Relay Therapeutics, Inc. (6.35%), Denali Therapeutics Inc. (6.05%), Twist Bioscience Co. (16.37%), Adaptive Biotechnologies Co. (8.08%), Kodiak Sciences Inc. (3.97%), CRISPR Therapeutics AG (18.98%), Ionis Pharmaceuticals, Inc. (6.98%), Repligen Co. (8.14%), Halozyme Therapeutics, Inc. (6.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Novavax stock? Short selling NVAX is an investing strategy that aims to generate trading profit from Novavax as its price is falling. NVAX shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Novavax? A short squeeze for Novavax occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVAX, which in turn drives the price of the stock up even further. How often is Novavax's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVAX, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: IOVA Short Interest Data RLAY Short Interest Data DNLI Short Interest Data TWST Short Interest Data ADPT Short Interest Data KOD Short Interest Data CRSP Short Interest Data IONS Short Interest Data RGEN Short Interest Data HALO Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NVAX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.